Scarica l'app Stockscreener
563.80
2.44%
-14.10
Dopo l'orario di chiusura:
565.32
1.52
+0.27%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché REGN Giù?
Forum
Previsione
Precedente Chiudi:
$577.90
Aprire:
$581.99
Volume 24 ore:
1.12M
Relative Volume:
0.96
Capitalizzazione di mercato:
$58.73B
Reddito:
$14.21B
Utile/perdita netta:
$4.46B
Rapporto P/E:
14.21
EPS:
39.68
Flusso di cassa netto:
$3.56B
1 W Prestazione:
-3.95%
1M Prestazione:
+0.88%
6M Prestazione:
-17.68%
1 anno Prestazione:
-51.76%
Intervallo 1D:
$562.78
$588.70
Intervallo di 1 settimana:
$562.78
$590.96
Portata 52W:
$476.49
$1,182.31
Regeneron Pharmaceuticals Inc Stock (REGN) Company Profile
Nome
Regeneron Pharmaceuticals Inc
Settore
Industria
Telefono
(914) 847-7000
Indirizzo
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
Confronta REGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.43 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
722.01 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.26 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Regeneron Pharmaceuticals Inc Stock (REGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-14 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-06-30 | Downgrade | Argus | Buy → Hold |
| 2025-05-30 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-05-30 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-14 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-04-22 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-02-05 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-01-16 | Downgrade | UBS | Buy → Neutral |
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-15 | Iniziato | Wolfe Research | Outperform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-09-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-12 | Iniziato | Bernstein | Outperform |
| 2024-01-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-08-21 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-08-21 | Reiterato | Oppenheimer | Perform |
| 2023-06-28 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-03-27 | Aggiornamento | SVB Securities | Market Perform → Outperform |
| 2023-03-24 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-03-23 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2023-01-30 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2023-01-20 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-10-26 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2022-10-17 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-09-09 | Aggiornamento | Jefferies | Underperform → Hold |
| 2022-09-09 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-07-25 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-07-13 | Iniziato | Cantor Fitzgerald | Neutral |
| 2022-06-06 | Iniziato | Jefferies | Underperform |
| 2022-05-23 | Iniziato | SVB Leerink | Outperform |
| 2022-01-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-01-03 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2021-12-15 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2021-12-09 | Ripresa | Wells Fargo | Overweight |
| 2021-12-07 | Ripresa | Cowen | Market Perform |
| 2021-12-06 | Iniziato | Goldman | Buy |
| 2021-11-19 | Ripresa | BMO Capital Markets | Outperform |
| 2021-11-05 | Downgrade | The Benchmark Company | Buy → Hold |
| 2021-06-29 | Iniziato | H.C. Wainwright | Buy |
| 2021-01-25 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2021-01-13 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2021-01-08 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-10-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-08-20 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-07-09 | Aggiornamento | SunTrust | Hold → Buy |
| 2020-05-26 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-04-28 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-17 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-04-08 | Iniziato | The Benchmark Company | Hold |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-02-26 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2020-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-02-25 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-02-11 | Aggiornamento | Argus | Hold → Buy |
| 2019-12-24 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-16 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-12-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-11-12 | Iniziato | SunTrust | Hold |
| 2019-11-07 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-09-23 | Aggiornamento | Guggenheim | Neutral → Buy |
Mostra tutto
Regeneron Pharmaceuticals Inc Borsa (REGN) Ultime notizie
Regeneron Pharmaceuticals’ Strategic Position in the 2025 Biotech Landscape - AInvest
Regeneron at Cantor Global Healthcare Conference: Strategic Growth and Challenges - Investing.com
Can Regeneron Pharmaceuticals Inc. reach all time highs this yearQuarterly Earnings Summary & Reliable Entry Point Trade Alerts - khodrobank.com
Prostate Cancer Pipeline Analysi, 2025 by DelveInsight | Pfizer, Janssen Pharmaceutical, POINT Biopharma, Tavanta Therapeutics, Exelixis, Astellas Pharma Inc., Antev, ORCA Therapeutics, Regeneron Phar - Barchart.com
Sporadic Inclusion Body Myositis Market: Epidemiology, - openPR.com
Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by GW Henssler & Associates Ltd. - MarketBeat
Key resistance and support levels for Regeneron Pharmaceuticals Inc.Portfolio Return Report & Free Accurate Trade Setup Notifications - Newser
Lansforsakringar Fondforvaltning AB publ Reduces Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
What candlestick patterns are forming on Regeneron Pharmaceuticals Inc.Market Risk Analysis & Growth Focused Entry Reports - Newser
How to track smart money flows in Regeneron Pharmaceuticals Inc.July 2025 Sector Moves & AI Enhanced Trading Alerts - Newser
Will Regeneron Pharmaceuticals Inc. outperform the marketOptions Play & Low Volatility Stock Recommendations - Newser
How Is Regeneron’s Stock Performance Compared to Other Pharma Stocks? - MSN
How Is Regeneron’s Stock Performance Compared To Other Pharma Stocks? - Barchart.com
The Manufacturers Life Insurance Company Increases Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals Inc. stock trend forecastJuly 2025 Movers & High Conviction Trade Alerts - Newser
Real time social sentiment graph for Regeneron Pharmaceuticals Inc. - Newser
OMERS ADMINISTRATION Corp Sells 639 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Te Ahumairangi Investment Management Ltd Makes New $896,000 Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Orion Investment Co Boosts Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Landscape Capital Management L.L.C. Takes $1.03 Million Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Magnetar Financial LLC Has $7.32 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
What are Regeneron Pharmaceuticals Inc.’s recent SEC filings showingJuly 2025 Pullbacks & Fast Gain Swing Trade Alerts - khodrobank.com
Momentum divergence signals in Regeneron Pharmaceuticals Inc. chartWeekly Earnings Recap & Low Risk High Win Rate Stock Picks - Newser
Intraday pattern recognizer results for Regeneron Pharmaceuticals Inc.July 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
Regeneron: Drug Pricing Woes Notwithstanding, Due For A Major Comeback (NASDAQ:REGN) - Seeking Alpha
Can Regeneron Pharmaceuticals Inc. expand its profit marginsWeekly Investment Recap & Accurate Entry/Exit Alerts - khodrobank.com
Wellington Management Group LLP Cuts Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Kestra Advisory Services LLC Reduces Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Evercore ISI Maintains a Buy on Regeneron Pharmaceuticals (REGN) With a $750 PT - MSN
Tema Etfs LLC Has $2.73 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
COPD Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma - Barchart.com
Regeneron Pharmaceuticals, Inc. $REGN is Armistice Capital LLC's 10th Largest Position - MarketBeat
What the charts say about Regeneron Pharmaceuticals Inc. todayStock Surge & Long-Term Safe Investment Plans - Newser
What makes Regeneron Pharmaceuticals Inc. stock price move sharplyPortfolio Value Report & Free Weekly Watchlist of Top Performers - Newser
Guggenheim Capital LLC Sells 4,547 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $781.00 - MarketBeat
Real time alert setup for Regeneron Pharmaceuticals Inc. performanceWeekly Loss Report & Reliable Entry Point Trade Alerts - Newser
What is Regeneron Pharmaceuticals Inc. s 5 year growth outlookWeekly Investment Recap & Expert Approved Trade Ideas - khodrobank.com
Regeneron Pharmaceuticals, Inc. $REGN Holdings Increased by Comerica Bank - MarketBeat
Analyzing Regeneron Pharmaceuticals Inc. with multi timeframe charts2025 Top Decliners & Expert Approved Trade Ideas - Newser
Will Regeneron Pharmaceuticals Inc. stock recover after earnings2025 Key Highlights & Expert Verified Movement Alerts - خودرو بانک
Canada Pension Plan Investment Board Decreases Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Ieq Capital LLC Acquires 4,381 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Tools to assess Regeneron Pharmaceuticals Inc.’s risk profileLayoff News & Free Weekly Chart Analysis and Trade Guides - Newser
How to contact the Daily Bulletin - FinancialContent
Key resistance and support levels for Regeneron Pharmaceuticals IncJuly 2025 Spike Watch & Reliable Price Breakout Alerts - Newser
Harvest Portfolios Group Inc. Acquires 11,555 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
CW Advisors LLC Purchases Shares of 1,428 Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals Inc Azioni (REGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.10%
1.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):